Logo image of YTEN

YIELD10 BIOSCIENCE INC (YTEN) Stock Price, Forecast & Analysis

USA - NASDAQ:YTEN - US98585K8541 - Common Stock

2.88 USD
-2.38 (-45.25%)
Last: 5/15/2024, 8:18:42 PM
2.89 USD
+0.01 (+0.35%)
After Hours: 5/15/2024, 8:18:42 PM

YTEN Key Statistics, Chart & Performance

Key Statistics
Market Cap44.35M
Revenue(TTM)60.00K
Net Income(TTM)-14456000
Shares15.40M
Float13.35M
52 Week High72.96
52 Week Low2.02
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-32.44
PEN/A
Fwd PEN/A
Earnings (Next)08-12 2024-08-12/amc
IPO2006-11-10
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


YTEN short term performance overview.The bars show the price performance of YTEN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

YTEN long term performance overview.The bars show the price performance of YTEN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of YTEN is 2.88 USD. In the past month the price decreased by -56.91%. In the past year, price decreased by -96.01%.

YIELD10 BIOSCIENCE INC / YTEN Daily stock chart

YTEN Latest News, Press Relases and Analysis

YTEN Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 22.94 382.94B
AMGN AMGEN INC 14.63 172.20B
GILD GILEAD SCIENCES INC 14.97 152.10B
VRTX VERTEX PHARMACEUTICALS INC 24.02 106.91B
REGN REGENERON PHARMACEUTICALS 14.31 68.28B
ALNY ALNYLAM PHARMACEUTICALS INC 852.08 56.96B
ARGX ARGENX SE - ADR 62.07 51.25B
INSM INSMED INC N/A 39.50B
ONC BEONE MEDICINES LTD-ADR 5.19 35.30B
NTRA NATERA INC N/A 27.44B
BNTX BIONTECH SE-ADR N/A 24.86B
BIIB BIOGEN INC 9.17 22.49B

About YTEN

Company Profile

YTEN logo image Yield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company is headquartered in Woburn, Massachusetts and currently employs 30 full-time employees. The company went IPO on 2006-11-10. The firm is using its differentiated trait gene discovery platform, the TraitFactory, to develop improved Camelina varieties for the production of seed products, and to discover high value genetic traits for the agriculture and food industries. The seed products include Camelina oil for use as a low carbon biofuel feedstock, Omega-3 oils for nutrition and PHA Bioplastics for biodegradable zero-waste packaging solutions. The company is developing the oilseed Camelina sativa (Camelina) as a platform crop for large scale production of low carbon sustainable seed products to address petroleum replacement markets, food and nutrition markets, and animal feed markets. The company is engaged in the development of elite Camelina germplasm exhibiting herbicide tolerance, disease resistance and other traits. The firm's development pipeline falls into three categories: input traits, performance traits and new seed product traits.

Company Info

YIELD10 BIOSCIENCE INC

19 Presidential Way Ste 201

Woburn MASSACHUSETTS 01801 US

CEO: Oliver P. Peoples

Employees: 30

YTEN Company Website

Phone: 16175831700

YIELD10 BIOSCIENCE INC / YTEN FAQ

Can you describe the business of YIELD10 BIOSCIENCE INC?

Yield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company is headquartered in Woburn, Massachusetts and currently employs 30 full-time employees. The company went IPO on 2006-11-10. The firm is using its differentiated trait gene discovery platform, the TraitFactory, to develop improved Camelina varieties for the production of seed products, and to discover high value genetic traits for the agriculture and food industries. The seed products include Camelina oil for use as a low carbon biofuel feedstock, Omega-3 oils for nutrition and PHA Bioplastics for biodegradable zero-waste packaging solutions. The company is developing the oilseed Camelina sativa (Camelina) as a platform crop for large scale production of low carbon sustainable seed products to address petroleum replacement markets, food and nutrition markets, and animal feed markets. The company is engaged in the development of elite Camelina germplasm exhibiting herbicide tolerance, disease resistance and other traits. The firm's development pipeline falls into three categories: input traits, performance traits and new seed product traits.


What is the current price of YTEN stock?

The current stock price of YTEN is 2.88 USD. The price decreased by -45.25% in the last trading session.


Does YTEN stock pay dividends?

YTEN does not pay a dividend.


What is the ChartMill rating of YIELD10 BIOSCIENCE INC stock?

YTEN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


What is the market capitalization of YTEN stock?

YIELD10 BIOSCIENCE INC (YTEN) has a market capitalization of 44.35M USD. This makes YTEN a Nano Cap stock.


Who owns YIELD10 BIOSCIENCE INC?

You can find the ownership structure of YIELD10 BIOSCIENCE INC (YTEN) on the Ownership tab.


YTEN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

YTEN Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to YTEN. YTEN has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

YTEN Financial Highlights

Over the last trailing twelve months YTEN reported a non-GAAP Earnings per Share(EPS) of -32.44. The EPS decreased by -1075.36% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -370%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-867.16%
Sales Q2Q%-100%
EPS 1Y (TTM)-1075.36%
Revenue 1Y (TTM)-86.67%

YTEN Forecast & Estimates

7 analysts have analysed YTEN and the average price target is 12.24 USD. This implies a price increase of 325% is expected in the next year compared to the current price of 2.88.

For the next year, analysts expect an EPS growth of 97.63% and a revenue growth 2712.5% for YTEN


Analysts
Analysts45.71
Price Target12.24 (325%)
EPS Next Y97.63%
Revenue Next Year2712.5%

YTEN Ownership

Ownership
Inst Owners1.81%
Ins Owners1.67%
Short Float %N/A
Short RatioN/A